AbbVie today announced that the European Commission (EC) granted marketing authorization to RINVOQ® (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in adult patients.

Cancer patients in British Columbia will no longer be referred to clinics in Bellingham, Wash., for care, Health Minister ...

Rashes are a common side effect of some prostate cancer treatments. Rarely, they may be caused by cancer cells.

Researchers developed light-activated cyanine-carborane salts that effectively target and destroy aggressive breast cancer ...

Researchers sought to understand the association between quality of life and cancer-related experiences of survivors with stage III/IV CRC.

Charles and Camilla arrive for Italy tour after King’s hospital stay due to cancer treatment - Charles to become first ...

Cancer patients experienced a fivefold decline in opioid dose prescriptions between 2016 and 2021, according to a study published March 26 in JCO Oncology Practice.  For the study, researchers from ...

RFK also claimed, “We spent zero on chronic disease during the Kennedy administration. Today we spend $4.3 trillion a year.” ...

A major step forward has been made in predicting how well melanoma patients would respond to treatment, thanks to ...

For some leukemia patients, each hour of delayed care can be the difference between life and death. JHU's Eugene Shenderov is ...

Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...

Learn to recognize the early warning signs of male urinary problems that often go unnoticed, plus the effective solutions for ...